San Diego Business Journal


Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Tease photo

Co. Acts as Patients’ Guide for Medical Tourism to Mexico

MEDICAL: Vetting Of Services Provides Key Information, Safety

South Doctors Inc, a downtown startup focused on medical tourism, is vetting the legitimacy of health care treatments sought across the border.

Planned Clinical Trial for Parkinson’s Treatment Would be a First

Biotech: Stem Cell Therapy Would Repair Damaged Brain Tissue

International Stem Cell Corp. is entering a human clinical trial to test if the company’s patented stem cell line will repair the brains of Parkinson’s patients.

FDA Grants Vical Inc. Infectious Disease Designation for Fungal Treatment

San Diego's Vical Inc. has won a "qualified infectious disease product" designation from the U.S. Food and Drug Administration for a proposed treatment of invasive aspergillosis, a potentially deadly fungal disease.

Quidel Announces Changes to Board of Directors

Quidel Corp., a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced that Mark A. Pulido has resigned as chairman of the company's Board of Directors, a position he had held for 11 years.

La Jolla Pharmaceutical Signs Agreement With Vanderbilt University

La Jolla Pharmaceutical Co. has signed an exclusive worldwide research and license agreement with Nashville’s Vanderbilt University relating to the university’s research on bone formation.

Tease photo

Johnson Lai Named CIO at NuVasive Inc.

Medical device maker NuVasive Inc. announced that Johnson Lai has been appointed chief information officer. Lai will be responsible for advancing the company’s information technology systems, process and procedures, according to a recent news release.

Contract for Anthrax Vaccine Potentially Worth $143.5M for Pfenex

San Diego-based Pfenex Inc. announced it has signed a five-year, cost-plus fixed-fee contract valued at up to $143.5 million with the Biomedical Advanced Research and Development Authority of the Department of Health and Human Services, for the advanced development of a mutant recombinant protective antigen anthrax vaccine.

Aethlon Medical Inc. Reports Fiscal 2016 Q1 Results

Aethlon Medical Inc., a maker of biofiltration devices to treat life-threatening diseases, announced results for the first quarter of fiscal 2016 ended June 30, 2015. The company said it had a cash balance of approximately $5.65 million at June 30.

Half-Dozen Life Science Firms Report Earnings

Six San Diego County life science firms reported quarterly earnings and corporate updates.

Neuropore Therapies Inc. Launches Phase 1 Clinical Trial For Parkinson's Treatment

Neuropore Therapies Inc., a biopharmaceutical company in San Diego, has launched Phase 1 clinical trials for its drug candidate NPT200-11, a potential treatment for Parkinson’s disease.

Imprimis Signs License Agreement With Advanced Dosage

Imprimis Pharmaceuticals Inc., a company developing drug combo formulations, announced Wednesday that it has entered into a license agreement with Advanced Dosage Forms Inc.

PatientSafe Solutions Appoints CFO

PatientSafe Solutions, which provides point-of-care mobile solutions for health care, has named Balaji Sekar its chief financial officer.

Scripps Health Launches Informational App

Scripps Health has launched a new app that provides patients and visitors with access to information about physicians and Scripps hospitals and clinics via smartphones and tablets.

DexCom, Google Partner on Diabetes-Related Products

Medical device maker DexCom is partnering with Google Life Sciences to develop a new generation of smaller, less expensive continuous glucose monitors (CGM) for people with diabetes.

Drugmaker Zogenix Reports Q2 Revenue of $7.4 Million

San Diego drugmaker Zogenix reported revenue of $7.4 million in the second quarter of 2015, up from $6.7 million in the same quarter last year.